Randomized controlled trial on the usefulness of hochuekkito for fatigue and anorexia during cancer chemotherapy
Phase 2
- Conditions
- Cancer
- Registration Number
- JPRN-UMIN000000985
- Lead Sponsor
- Multidisciplinary Cancer Center, Kanazawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Present illness: no limitation Past history: no limitation Combined treatment: no limitation Combined drugs: Kampo drugs other than hochuekkito, and vitamins etc can be continued. New addition of these drugs is prohibited.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective symptoms such as fatigue and anorexia, and quality of life
- Secondary Outcome Measures
Name Time Method Rate of treatment accomplishment, dose intensity, and median survival time